Chemaxon is a leading cheminformatics company, setting the industry standard for quality and accuracy. Over 1 million scientists, academics, and researchers use our tools to streamline their workflows and power their scientific breakthroughs.
Chemaxon joined Certara in 2024 to close gaps in the design-make-test-analyze cycle, bring promising leads into biosimulation, and speed up the launch of new medicines.
Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. Optibrium’s lead product, StarDrop™, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDrop™ enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. The company’s new Augmented Chemistry™ products and services deliver ground-breaking artificial intelligence technologies that continuously learn from all available data to supplement your experience and skills.
Founded in 2009, Optibrium is headquartered in Cambridge, UK with offices in Boston and San Francisco, USA. Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of the drug discovery process. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotech and academic groups.
Bioinformatics Solutions Inc. develops advanced algorithms based on innovative research, providing solutions to fundamental bioinformatics problems. This small, adaptable group is committed to serving the needs of pharmaceutical, biotechnological and academic scientists; and to the progression of drug discovery research. The company, founded in 2000 in Waterloo, Canada, comprises a select group of talented, award-winning, and intelligent developers, scientists and sales people.